Country for PR: United States
Contributor: PR Newswire New York
Friday, December 10 2021 - 02:00
AsiaNet
Cordis Names George Adams, MD as Chief Medical Officer
MIAMI LAKES, Fla., Dec. 10, 2021 /PRNewswire-AsiaNet/ --

-- Globally recognized interventional cardiologist is the latest addition to a 
growing leadership team

Cordis, a global cardiovascular technology company, today announced George 
Adams, MD, MHS, MBA, FACC, FSCAI as Chief Medical Officer, furthering the 
organization's mission to differentiate itself as a technological leader and 
value-based global medical device company.

Photo - https://mma.prnewswire.com/media/1704164/NewPictureGeorgeAdamsMD.jpg  
Logo - https://mma.prnewswire.com/media/1703651/Cordis_logo_R___jpeg_Logo.jpg 

"We are delighted to have Dr. Adams join our team as we continue to build the 
new Cordis," said CEO Shar Matin. "His depth of expertise in the treatment of 
both complex coronary and peripheral vascular disease will play a vital role in 
furthering our mission to improve patient care at pace with cost-effective, 
differentiated solutions that build on our legacy of innovation."

Dr. Adams comes to Cordis with a distinguished combination of clinical 
practice, medical research, and product development experience. He is globally 
recognized for his expertise in the treatment of peripheral vascular disease in 
patients with critical limb ischemia (CLI) and treatment of coronary artery 
disease in patients with acute coronary syndromes. He is involved in the 
development of regional and national systems of care for the treatment of CLI, 
ST-Elevation Myocardial Infarction (STEMI), and management of complex coronary 
and peripheral vascular disease. He has a well-established network of peers and 
associates who are viewed as key opinion leaders within the global 
cardiovascular community.

Dr. Adams plays an integral role in global peer education. He strives to 
advance the field of medicine through leadership and moderation of, as well as 
participation in, numerous cardiovascular and peripheral vascular forums 
spanning national and global platforms.

He is a sought-after speaker and well-published researcher, serving as primary 
investigator for multiple clinical trials. He is certified by The American 
Board of Internal Medicine in internal medicine and cardiovascular disease.

"It is with great honor and excitement that I join the Cordis team as Chief 
Medical Officer," said Dr. Adams.  "I look forward to playing a role in 
reinvigorating an incredible 62-year legacy.  I am grateful to be a part of the 
future that Cordis is building with integrity and a vision for innovation."

About Cordis

Cordis is a worldwide leader in the development and manufacturing of 
interventional cardiovascular technologies with a more than 60-year history of 
pioneering breakthrough therapies to treat millions of patients. With a 
reputation for clinical acumen, training, and services, Cordis established a 
legacy of innovation in high-quality and minimally invasive cardiovascular 
products and built a strong global footprint with operations in more than 60 
countries around the world.

Contact: 
Kurt Haggstrom, Vice President, Global Marketing 
Phone: 949-244-7382 
Email: kurt.haggstrom@cardinalhealth.com 

SOURCE: Cordis
Translations

Japanese